Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | IRON | COMMON STOCK | 2.34M | Dec 29, 2022 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Effective as of December 29, 2022 (the "Effective Time"), a wholly-owned subsidiary of Gemini Therapeutics, Inc. ("Gemini"), merged (the "Merger") with and into Disc Medicine, Inc. ("Disc") resulting in, among other things, Disc becoming a wholly owned subsidiary of Gemini. At the Effective Time, Gemini effected a name change to "Disc Medicine, Inc." (hereinafter, the "Issuer"). |
F2 | Represents the number of shares of common stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of Disc held by the Reporting Person prior to the Merger. Each share of Disc common stock held at the Effective Time was exchanged for 0.1096 shares of the Issuer's common stock, which gives effect to the reverse split of common stock effected by the Issuer and the Merger exchange ratio. |